Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer-Reference-Cited by-同舟云学术

Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer

Published:2017 Issue:2 Volume:12 Page:112-119
ISSN:1880-487X
Container-title:Journal of Rural Medicine
language:en
Short-container-title:J Rural Med

Author:

Kubota Hiroki¹,Fukuta Katsuhiro¹,Yamada Kenji²,Hirose Masahito¹,Naruyama Hiromichi¹,Yanai Yoshimasa¹,Yamada Yasuyuki¹,Watase Hideki²,Kawai Noriyasu²,Tozawa Keiichi²,Yasui Takahiro²

Affiliation:

1. Department of Urology, The Aichi Prefectural Federation of Agricultural Cooperatives for Health andWelfare Kainan Hospital, Aichi, Japan

2. Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Publisher

Japanese Association of Rural Medicine

Link

https://www.jstage.jst.go.jp/article/jrm/12/2/12_2938/_pdf

Reference29 articles.

1. 1. The Japanese Urological Association, editor. Guidelines for the diagnosis and treatment of prostate cancer 2006 edition. Kanehara Publishing, 2006.

2. 2. Akaza H. Future prospects for luteinizing hormone-releasing hormone analogues in prostate cancer treatment. Pharmacology 2010; 85: 110–120.

3. 3. Cooperberg MR, Hinotsu S, Namiki M, et al. Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer. BJU Int 2016; 117: 102–109.

4. 4. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34–45.

5. 5. Petrylak DP, Tangen CM, Hussain MH, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351: 1513–1520.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives;Cancer Treatment Reviews;2024-11

2. Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer;BMC Cancer;2023-04-04

3. Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review;Journal of Clinical Medicine;2022-05-15

4. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy;Journal of Experimental Pharmacology;2021-03

5. Rethinking Alkylating(-Like) Agents for Solid Tumor Management;Trends in Pharmacological Sciences;2019-05